I'm of the opinion when a stock is hot and has a lot of $$$ built into it's stock price on "success" of a trial or potential approval of a drug they should always raise some cash as a hedge. Far too many times I have seen somethnig like DNDN where they issue LOADS of debt near the top of equity valuation and then in 2 years are nearly bankrupt - HGSI comes to mind a few years ago.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.